Faes Farma seeks growth through acquisitions
Faes Farma buscará crecer mediante adquisiciones
Intel ID : 237944
| Synopsis |
|
Faes Farma (BME: FAE), a Spanish pharmaceutical company, continues to look for acquisition opportunities for growth, as published by newspaper El Economista on 22 June 2016. Its president, Mariano Ucar Angulo, said they have not carried out any acquisition yet, because opportunities were not right.
(content in spanish)
Faes Farma (BME: FAE), empresa farmacéutica española, continúa buscando oportunidades para crecer mediante adquisiciones, según ha señalado el diario El Economista el 22 de junio de 2016. Su presidente, Mariano Ucar Angulo, ha señalado que si aún no se ha hecho ninguna adquisición es porque no se han dado las oportunidades. |
|
||||
| Intel ID | 237944 | |
| Value | ND | |
| Native Currency | Euro (EUR) | |
|
Financial Data - Faes Farma
(31 Dec 2023) |
Revenue: EUR 476,92m EBITDA: EUR 122,24m |
|
| Date |
 |
|
| Country | |
|
| Region | ||
| Continent |  |
|
| Geography | |
|
| Subsector (Old TTR Sectors) |
|
|
| Type |
|
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Secondary Sectors (TTRSC) |
30.01.01 Biopharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals 30.01.04 Specialty Pharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.